Uric Acid and Surgical Prognosis

Completed

• Conditions: Uric Acid

• Registration Number: NCT06837545
• Lead Sponsor: Asan Medical Center

Brief Summary

Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery.

Detailed Description

Preoperative SUA levels demonstrate a nonlinear, sex-specific relationship with postoperative outcomes in non-cardiac surgery.

Study Timeline

• Study Start: 2024-07-30
• Primary Completion: 2024-12-20
• Study Completion: 2025-01-02
• Status Verified: 2025-02
• Study First Submitted: 2025-02-15
• Study First Submitted QC: 2025-02-15
• Last Update Submitted: 2025-02-15
• Study First Posted: 2025-02-20
• Last Update Posted: 2025-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 309353

Inclusion Criteria

• Patients aged 18 years or older
• Patients who underwent non-cardiac surgery

Exclusion Criteria

• Emergency surgery
• Pregnancy
• Cadavers
• Patients with missing preoperative SUA values or no follow-up after surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
30-day postoperative mortality	30 days post-surgery	The primary outcome measure is the incidence of 30-day postoperative mortality in patients undergoing non-cardiac surgeries. Mortality is defined as death occurring within 30 days following the surgery.

Trial Locations

Locations (1)

Asan Medical Center; 🇰🇷 Seoul, Songpa, Korea, Republic of